PRDM8

PRDM8 is a transcriptional repressor and H3K9 histone methyltransferase that controls neural circuit assembly, cortical lamination, retinal cell survival, and spinal cord progenitor fate specification. PRDM8 possesses intrinsic histone methyltransferase activity that specifically methylates H3K9 to silence target gene promoters, including steroidogenic genes (p450c17, LHR), Cadherin-11, and Ebf3 (PMID:19646955, PMID:22284184, PMID:29113800). It is recruited to DNA through a complex with the bHLH transcription factor Bhlhb5/Bhlhe22, and genetic loss of either partner produces identical neural circuit phenotypes (PMID:22284184). In the developing nervous system, PRDM8 regulates the multipolar-to-bipolar transition of migrating neocortical neurons, specifies upper-layer cortical neuron identity, maintains retinal bipolar cell survival, and modulates Sonic Hedgehog signaling to control the motor neuron-to-oligodendrocyte precursor switch (PMID:24489718, PMID:26283595, PMID:26023183, PMID:32680935).

1. 2009 High

   Establishing that PRDM8 is an enzyme: in vitro assays demonstrated intrinsic H3K9 methyltransferase activity and direct recruitment to steroidogenic gene promoters, providing the first mechanistic basis for PRDM8 as a transcriptional repressor via histone modification.

   Evidence In vitro HMTase assay with substrate specificity determination, ChIP showing promoter occupancy, reporter repression assay in mouse testis cells

   PMID:19646955

   Open questions at the time

   • Whether H3K9 methylation is mono-, di-, or trimethylation was not fully resolved
   • Whether PRDM8 requires cofactors for catalysis in vivo was not tested
   • Relevance of steroidogenic gene repression beyond testis was unknown
2. 2012 High

   Identifying the DNA-targeting mechanism: PRDM8 forms a complex with Bhlhb5 (Bhlhe22), which provides sequence-specific DNA binding, and genetic epistasis showed that loss of either partner produces identical neural circuit assembly defects, establishing the functional unit of PRDM8 repression.

   Evidence Reciprocal co-immunoprecipitation, parallel Prdm8-KO and Bhlhb5-KO mice with identical behavioral and cellular phenotypes, identification of Cadherin-11 as a target gene

   PMID:22284184

   Open questions at the time

   • Whether PRDM8 can function independently of Bhlhb5 in non-neural tissues was not addressed
   • Structural basis of the PRDM8–Bhlhb5 interaction is unknown
   • Full repertoire of target genes was not defined
3. 2014 Medium

   Defining a specific developmental role: PRDM8 controls the multipolar-to-bipolar morphological transition during neocortical neuron migration by repressing guidance molecule genes, placing its repressor activity in a precise temporal window of cortical development.

   Evidence In utero electroporation with gain- and loss-of-function constructs in mouse neocortex, Prdm8-mVenus reporter

   PMID:24489718

   Open questions at the time

   • Which specific guidance molecule genes are direct targets was not resolved by ChIP
   • Whether PRDM8 enzymatic activity is required for this function was not tested
   • The signaling trigger that terminates PRDM8 expression in bipolar cells was unknown
4. 2015 Medium

   Extending PRDM8 function to cortical layer specification and retinal cell survival: Prdm8-null mice show selective loss of upper-layer cortical neurons and retinal bipolar cell types, revealing roles in both specification and maintenance of post-mitotic neuronal populations.

   Evidence Homozygous Prdm8 KO mice with cortical layer thickness quantification; Prdm8-EGFP null mice with electroretinography and retinal cell counting

   PMID:26023183 PMID:26283595

   Open questions at the time

   • Whether upper-layer neuron loss reflects failed specification versus apoptosis was not distinguished
   • Direct target genes mediating bipolar cell survival (beyond PKCα) were not established by ChIP
   • Whether Bhlhb5 is the obligate partner in retina was not tested
5. 2017 Medium

   Identifying the Ebf3–NeuroD1 transcriptional cascade downstream of PRDM8: Ebf3 was identified as a direct repression target, and its derepression upon Prdm8 loss activates NeuroD1 to drive premature morphological transition, linking PRDM8 to a defined gene regulatory hierarchy.

   Evidence In utero electroporation knockdown of Prdm8 with target gene expression analysis; Ebf3 knockdown and NeuroD1 overexpression rescue experiments

   PMID:29113800

   Open questions at the time

   • Direct binding of PRDM8 to the Ebf3 promoter was not demonstrated by ChIP
   • Whether Ebf3 repression requires H3K9 methyltransferase activity of PRDM8 was not tested
6. 2018 Medium

   Demonstrating PRDM8 tumor-suppressive activity: PRDM8 suppresses PI3K/AKT/mTOR signaling in hepatocellular carcinoma through regulation of NAP1L1, expanding its functional relevance beyond neurodevelopment.

   Evidence Lentiviral overexpression and knockdown in HCC cell lines, in vivo xenograft model, pathway component analysis

   PMID:29572888

   Open questions at the time

   • Whether NAP1L1 is a direct transcriptional target of PRDM8 was not established
   • The mechanistic link between H3K9 methylation and PI3K/AKT/mTOR suppression was not reconstituted
   • Generalizability to other cancer types was not shown
7. 2020 Medium

   Confirming H3K9 methyltransferase activity in a cellular context and broadening developmental roles: CRISPR silencing in Merkel cell carcinoma reduced H3K9 methylation; zebrafish prdm8 mutants revealed modulation of Shh signaling in motor neuron–OPC fate switching; and human iPSC knockouts impaired both hematopoietic and neuronal differentiation.

   Evidence CRISPR KO in MCC cells with H3K9me immunohistochemistry; zebrafish prdm8 mutant with pharmacological Shh inhibition rescue; CRISPR KO in human iPSCs with differentiation assays

   PMID:32344701 PMID:32680935 PMID:32819411

   Open questions at the time

   • Whether Shh pathway genes are direct PRDM8 targets or indirectly regulated was not established
   • The mechanism by which PRDM8 influences hematopoietic lineage specification is unknown
   • Genome-wide binding profiles for PRDM8 have not been reported

• Major open questions include the genome-wide direct target repertoire of PRDM8 (no ChIP-seq available), the structural basis of the PRDM8–Bhlhe22 interaction, whether PRDM8 enzymatic activity versus scaffolding function is required for each developmental phenotype, and the identity of PRDM8 partners outside the nervous system.
• No genome-wide binding or target gene map exists
• Enzymatic versus scaffolding contributions have not been separated by catalytic-dead mutants
• Non-neural partner proteins are unidentified